Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    Fingolimod for multiple sclerosis.

    Pelletier D, Hafler DA.

    N Engl J Med. 2012 Jan 26;366(4):339-47. Review. No abstract available.

    PMID:
    22276823
    [PubMed - indexed for MEDLINE]
    2.

    Inflammation in multiple sclerosis--sorting out the gray matter.

    Calabresi PA.

    N Engl J Med. 2011 Dec 8;365(23):2231-3. No abstract available.

    PMID:
    22150043
    [PubMed - indexed for MEDLINE]
    3.

    Inflammatory cortical demyelination in early multiple sclerosis.

    Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM.

    N Engl J Med. 2011 Dec 8;365(23):2188-97.

    PMID:
    22150037
    [PubMed - indexed for MEDLINE]
    4.

    Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

    O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group.

    N Engl J Med. 2011 Oct 6;365(14):1293-303.

    PMID:
    21991951
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Images in clinical medicine. Baló's concentric sclerosis.

    Wengert O, Siebert E.

    N Engl J Med. 2011 Aug 25;365(8):742. No abstract available.

    PMID:
    21864168
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Oral cladribine and fingolimod for relapsing multiple sclerosis.

    Mann H.

    N Engl J Med. 2010 May 6;362(18):1738; author reply 1739-40. No abstract available.

    PMID:
    20445188
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Oral cladribine and fingolimod for relapsing multiple sclerosis.

    Li H, Zhang X.

    N Engl J Med. 2010 May 6;362(18):1738-9; author reply 1739-40. No abstract available. Erratum in: N Engl J Med. 2010 Jul 15;363(3):298.

    PMID:
    20449878
    [PubMed - indexed for MEDLINE]
    8.

    A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

    Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group.

    N Engl J Med. 2010 Feb 4;362(5):416-26. Epub 2010 Jan 20.

    PMID:
    20089960
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Oral therapy for multiple sclerosis--sea change or incremental step?

    Carroll WM.

    N Engl J Med. 2010 Feb 4;362(5):456-8. Epub 2010 Jan 20. No abstract available.

    PMID:
    20089958
    [PubMed - indexed for MEDLINE]
    10.

    Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

    Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group.

    N Engl J Med. 2010 Feb 4;362(5):402-15. Epub 2010 Jan 20.

    PMID:
    20089954
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

    Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group.

    N Engl J Med. 2010 Feb 4;362(5):387-401. Epub 2010 Jan 20.

    PMID:
    20089952
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk